Who owns Tiziana Life Sciences Ltd, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
Chernett Jorey: 5.4% · 6,476,471 shares
LAURA NATALIA MONICA FONDA: 5.7% · 6,805,556 shares
Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Tiziana Life Sciences Ltd they hold. Together these 1 managers report 0.00% of shares outstanding.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| AlphaMark Advisors, LLC | $309K | 4,589 | 0.11% | 0.00% | June 30, 2024 |
Funds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 7 funds hold 0.85% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| iShares Biotechnology ETF | $808K | 0.01% | 0.46% | September 30, 2021 |
| SPDR Portfolio Developed World ex- US ETF | $262K | 0.00% | 0.15% | September 30, 2021 |
5 more funds behind a free account
See every fund holding Tiziana Life Sciences Ltd and what share of its net assets the position represents.
Sign up freeLoading...
